MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN
Open Access
- 9 January 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (8) , 13450-13463
Abstract
MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASNKeywords
This publication has 32 references indexed in Scilit:
- Coordinated miRNA/mRNA Expression Profiles for Understanding Breed-Specific Metabolic Characters of Liver between Erhualian and Large White PigsPLOS ONE, 2012
- Long-term, efficient inhibition of microRNA function in mice using rAAV vectorsNature Methods, 2012
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative studyHepatology, 2011
- Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesProceedings of the National Academy of Sciences, 2011
- The Art of MicroRNA ResearchCirculation Research, 2011
- Combined Paracrine and Endocrine AAV9 mediated Expression of Hepatocyte Growth Factor for the Treatment of Renal FibrosisMolecular Therapy, 2010
- Specific role for acyl CoAHepatology, 2009
- MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targetsJournal of Clinical Investigation, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1Journal of Clinical Investigation, 2002